Neuropsicofarmacología molecular
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (2)
2007
-
Neuroprotective actions of noradrenaline: Effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta
Journal of Neurochemistry, Vol. 103, Núm. 5, pp. 2092-2101
2005
-
Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia
Neurobiology of Disease, Vol. 18, Núm. 2, pp. 375-384